Efficacy and Safety Clinical Trial
Official title:
Treatment of Refractory Crohn's Disease Lesions by Local Injection of Mesenchymal Stem Cells
The main objective is to assess the efficacy of local injection of MSC on the healing of refractory intestinal and perianal lesions in crohn disease. The second co-primary endpoint is safety.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04759534 -
Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia
|
Phase 3 | |
Not yet recruiting |
NCT05532111 -
Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
|
N/A | |
Active, not recruiting |
NCT04284215 -
Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC
|
N/A | |
Completed |
NCT06202456 -
A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver
|
Phase 4 | |
Completed |
NCT04870606 -
Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness
|
Phase 3 | |
Completed |
NCT03660761 -
Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03794778 -
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
|
Phase 4 | |
Recruiting |
NCT03255343 -
Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim
|
N/A | |
Recruiting |
NCT04197544 -
Evaluation of the Implantation of the End-vascular Creation of the Arteriovenous Fistulas in Patients in the University Hospital of Araba. Pilot Study.
|
N/A | |
Recruiting |
NCT04518501 -
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03779776 -
The Efficacy and Safety of Early Vitamin AD Supplementation in Very Preterm Infants
|
N/A | |
Not yet recruiting |
NCT06218004 -
Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT02809079 -
Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients
|
Phase 4 | |
Active, not recruiting |
NCT06194188 -
A Phase 2 Clinical Study of CU-20401
|
Phase 2 | |
Completed |
NCT03826004 -
Clemastine in Cardiovascular Surgery
|
N/A | |
Active, not recruiting |
NCT03623776 -
Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.
|
Phase 2 | |
Recruiting |
NCT04078399 -
Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence
|
N/A | |
Not yet recruiting |
NCT06351735 -
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
|
||
Not yet recruiting |
NCT06383078 -
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
|
Phase 2 | |
Withdrawn |
NCT05481775 -
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
|
Phase 2 |